Clinical Trial Update: A Dose Escalation Phase I Study of PDC-1421 Capsule Targeting in Depression [Phase 1]

View source ↗

Summary

Phase I dose-escalation study of PDC-1421 capsule targeting in major depressive disorder completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• PDC-1421

Snippet

Sponsor: BioLite, Inc. | Conditions: Major Depressive Disorder | Phase 1 | Status: COMPLETED | Results posted: 2014-09-22